Teva Pharma (TEVA): Rasio kapitalisasi marang pendapatan

Simbol lan logo merek Teva Pharmaceutical Industries Ltd. (TEVA)

Teva Pharmaceutical Industries is optimizing global distribution and implementing production line robotics with digital reporting. The median P/S confirms the efficiency of these processes, with the value holding at 2.90. Business stability is based on the production of high-demand essential medicines and established distribution channels through medical institutions and pharmacy chains.

Kapitalisasi marang pendapatan Teva Pharmaceutical Industries (TEVA): kanggo periode 04.07.2022 - 18.11.2026

Teva Pharmaceutical Industries (TEVA) - rincian metrik lan laporan keuangan

- rega lan prakiraan konsensus rega:
Produk seri Teva Pharmaceutical Industries Ltd.

For Teva Pharmaceutical Industries (TEVA), which combines the mass generic market with high-margin innovations in CNS therapy, this indicator determines the market value of every dollar of revenue. By analyzing the P/S market multiple, an investor assesses the efficiency of sales monetization relative to capitalization, where extreme peaks signal that the asset is overbought, while deep drawdowns indicate that the business is undervalued in the current cycle.